 BRIDGEWATER, N.J., Aug. 12, 2021 GLOBE NEWSWIRE -- Osmotica Pharmaceuticals plc Nasdaq: OSMT Osmotica or the Company, a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and James JD Schaub, Chief Operating Officer, will present at the H.C. Wainwright Ophthalmology Virtual Conference as follows: 